Frost & Sullivan

OCTOBER 26, 2023

SAN ANTONIO, TX — October 26, 2023 — The best in business gathered in Huntington Beach, CA at the 2023 Frost & Sullivan Best Practices Awards Gala held at the Hyatt Regency Huntington Beach Resort. The gathering honored top business achievements of some of the most innovative and successful companies in their fields.

Biotech 52

Biotech Contract research organization 52

Frost & Sullivan

AUGUST 6, 2023

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

Frost & Sullivan

MAY 3, 2023

4 th May 2023 – Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes George Clinical with the 2023 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX. –

Contract research organization 52

Contract research organization Biopharmaceuticals Biopharma Business development 52

Frost & Sullivan

AUGUST 29, 2024

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. increase from 2022. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52

Frost & Sullivan

OCTOBER 11, 2024

San Antonio, TX — 14 th October 2024 — Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award.

Biotech 52

Biotech Contract research organization Strategic partnership Collaboration 52

Frost & Sullivan

MARCH 22, 2024

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. What is driving transformation in the pharma industry? increase from 2022. However, the pharma/biopharma industry shows overall stagnant R&D activity.

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

Frost & Sullivan

FEBRUARY 15, 2024

Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape.

Ecosystems 40

Ecosystems Contract research organization Biotech Utilities 40